Dialysis providers oppose longer coverage of kidney transplant drugs

12/15/2009 | NYTimes.com

The National Kidney Foundation joined drugmakers and dialysis providers in opposing a measure in Congress that would extend Medicare coverage beyond 36 months for immunosuppressant drugs given to patients after a kidney transplant because they say it would be paid for by reducing reimbursements to dialysis patients. Kidney Care Partners, a coalition of dialysis providers, drugmakers and others, said although the bundled-payment method would help one group of patients, it "would potentially put another very vulnerable group of patients at risk."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC